1. Benedict K, Ireland M, Weinberg MP, Gruninger RJ, Weigand J, Chen L, Perez-Lockett K, Bledsoe C, Denny L, Cibulskas K, Gibbons-Burgener S, Kocharian A, DeBess E, Miller TK, Lepp A, Cronquist L, Warren K, Serrano JA, Loveland C, Turabelidze G, McCotter O, Jackson BR. Enhanced surveillance for coccidioidomycosis, 14 US states, 2016. Emerg Infect Dis. 2018;24:1444–52.
2. Marsden-Haug N, Goldoft M, Ralston C, Limaye AP, Chua J, Hill H, Jecha L, Thompson GR 3rd, Chiller T. Coccidioidomycosis acquired in Washington state. Clin Infect Dis. 2013;56:847–50.
3. Hirschmann JV. The early history of coccidioidomycosis: 1892–1945. Clin Infect Dis. 2007;44:1202–7.
4. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, Kusne S, Ho S, Seville MT, Parish JM. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014;20:983–90.
5. Summary of selected reportable diseases. 2018. [cited 2019 4/08/2019]. Available from: https://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/disease-data-statistics-reports/data-statistics-archive/2018/2018-ytd-communicable-disease-summary.pdf.